Prime presents at: GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress on Sept. 11 - Prime Therapeutics
Prime presents at: GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress on Sept. 11
Event on Sept. 11 in Washington D.C. will feature the latest information on using GLP-1s to tackle the obesity epidemic.
While glucagon-like peptide-1 (GLP-1) agonist medications are a popular approach to treating obesity, combining the use of this class of medications with lifestyle modifications may be the answer to both creating successful patient outcomes and managing health care spend. That’s the topic of a Sept. 11 discussion at the Hart Senate Office Building 902 in Washington D.C. Panelists will discuss research, possible policy implications and solutions, as well as share the strengths and limitations of GLP-1s as a tool to tackle the obesity epidemic.
Event:
GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress
Date/time:
Wednesday, Sept. 11 | 12–1 p.m. ET
Moderator:
- Danielle Nierenberg, president and founder, Food Tank
Panelists:
- Dariush Mozaffarian, director, Tufts Food is Medicine Institute
- Pat Gleason, assistant vice president, health outcomes at Prime Therapeutics
- Others TBD
About Prime Therapeutics
Prime Therapeutics LLC (Prime) offers innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. That means we challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to our customers and members. For more information, follow us on LinkedIn.